Received Mar 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Atopic dermatitis; This is a spontaneous report received from a Consumer or other non HCP. A female patient received BNT162b2 (COMIRNATY), on 24Oct2021 as dose 1, single (Batch/Lot number: unknown) and on 14Nov2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DERMATITIS ATOPIC (non-serious), outcome "unknown", described as "Atopic dermatitis". Additional information: During an inbound call, the consumer reported an adverse event. The consumer stated she never had a history of skin issues until she received the COVID vaccine. The consumer stated that the first Pfizer COVID vaccine dose was received on 24Ooct2021 and then a second dose on 14Nov2021. Unknown onset date of her skin condition. The consumer thinks that COVID vaccine caused her to develop atopic dermatitis. Batch/lot number is not provided, and it cannot be obtained.